ArticleBMC bioinformatics2025
EDRMM: enhancing drug recommendation via multi-granularity and multi-attribute representation.
Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDrug recommendation is a crucial application of artificial intelligence in medical practice. Although many models have been proposed to solve this task, two challenges remain unresolved: (i) most existing models use all historical visits as input, overlooking fine-grained correlations between historical and current information; (ii) Electronic Health Records (EHRs) are underutilized, with only partial information considered to describe patient conditions. To tackle the challenges, we propose a novel drug recommendation model, denoted by EDRMM, which incorporates multi-granularity and multi-attribute information into representation learning. We develop a longitudinal attribute-level history selection mechanism to effectively identify fine-grained historical information that is highly relevant to a patient's current clinical conditions. We analyze the impact of key Electronic Health Record (EHR) attributes, demonstrating that incorporating such attributes into patient representations can further boost performance. We also design an adaptive global Drug-Drug Interaction (DDI) risk regularization term for the DDI loss function to better balance accuracy and safety during training.
resultsExperimental results show that our model achieves state-of-the-art performance on a widely used MIMIC-III dataset.
conclusionsEDRMM overcomes two key drug recommendation limitations through three innovations: (1) Dynamic attribute-level history selection, which retrieves relevant features and filters out noise, (2) The integration of multi-attribute EHR with attribute-specific encoding strategies to generate comprehensive patient representations, and (3) Hybrid optimization balancing accuracy and safety via adaptive DDI regularization. The combination of these three innovations enables the proposed EDRMM to achieve the best recommendation performance on the MIMIC-III dataset.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.